A new study shows, for the first time, how the human genome folds and moves in 3D over time to control when genes turn on and ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will ...

Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...

When most of us think of DNA, we have a vague idea it's made up of genes that give us our physical features, our behavioural ...

Over the past six months, Natera has been a great trade, beating the S&P 500 by 24.2%. Its stock price has climbed to $235.65 ...

Breakthrough study shows inexpensive resveratrol and copper supplements "dramatically weakened" deadly glioblastoma brain ...

OpEd: Multicancer early detection is the next frontier in cancer prevention and treatment, and it needs to be adopted widely.

CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...